Biotech · Private company
Kyowa Hakko Kirin Pharma, Inc.
Track this companyFree. Adds Kyowa Hakko Kirin Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials160 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials16
- Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)EARLY_PHASE1 · SUSPENDED · started Jan 18, 2024ClinicalTrials.gov NCT06235281 · fetched Nov 12, 2026
- A Study to Evaluate Abuse Potential of IstradefyllinePHASE1 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02609477 · fetched Nov 12, 2026
- Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's DiseasePHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02610231 · fetched Nov 12, 2026
- Effect of Mild Hepatic Impairment on the Pharmacokinetics of IstradefyllinePHASE1 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT02256033 · fetched Nov 12, 2026
- The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.PHASE1 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02174250 · fetched Nov 12, 2026
- A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's DiseasePHASE3 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01968031 · fetched Nov 12, 2026
- An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaPHASE1_PHASE2 · COMPLETED · started Feb 1, 2012ClinicalTrials.gov NCT01571596 · fetched Nov 12, 2026
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerPHASE1 · TERMINATED · started Jan 1, 2011ClinicalTrials.gov NCT01279291 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerPHASE1 · TERMINATED · started Dec 1, 2010ClinicalTrials.gov NCT01199367 · fetched Nov 12, 2026
- Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001PHASE2 · COMPLETED · started Aug 1, 2010ClinicalTrials.gov NCT01226472 · fetched Nov 12, 2026
- A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaPHASE1_PHASE2 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01063907 · fetched Nov 12, 2026
- Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid TumorPHASE1 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00921336 · fetched Nov 12, 2026
- Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell LymphomaPHASE1_PHASE2 · COMPLETED · started May 1, 2009ClinicalTrials.gov NCT00888927 · fetched Nov 12, 2026
- Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerPHASE1_PHASE2 · TERMINATED · started Mar 1, 2009ClinicalTrials.gov NCT00838578 · fetched Nov 12, 2026
- A Study of KRN23 in X-linked HypophosphatemiaPHASE1 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00830674 · fetched Nov 12, 2026
- Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple MyelomaPHASE1 · TERMINATED · started Oct 1, 2008ClinicalTrials.gov NCT00775502 · fetched Nov 12, 2026